Clinical Trial Update: Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating senolytic and anti-fibrotic agents to enhance the beneficial effects of bone marrow stem cells for knee osteoarthritis is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• Bone marrow stem cells
• Senolytic and anti-fibrotic agents (investigational)

Snippet

Sponsor: Steadman Philippon Research Institute | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING